文献速递功能神经外科神经重症

微血管减压术与立体定向放射外科治疗三叉神经痛的长期结局比较

Outcomes of Microvascular Decompression Versus Stereotactic Radiosurgery in the Treatment of Trigeminal Neuralgia: A Decades-Long, Single-Center Retrospective Cohort Analysis.
PubMed 文献 · Neurosurgery · 2026-10-30

该单中心回顾性队列研究纳入2001年9月至2025年5月间接受微血管减压术(MVD)或立体定向放射外科(SRS)的290例1型三叉神经痛患者,比较两种一线干预的长期疗效与安全性。控制年龄和性别后,MVD在初始疼痛缓解和复发率上优于SRS,但并发症发生率更高;SRS无并发症但面部麻木更常见。

要点

  • MVD初始疼痛缓解更优(BNI 1.74 vs 1.96),复发率更低(7.9% vs 22.6%)。
  • SRS后面部麻木更常见(34.5% vs 8.6%),MVD并发症率13.7%但多为轻微。
  • 术前MRI血管冲突预测MVD复发更低(7.9% vs 22.5%),无冲突时可考虑神经松解术。

核心结论

  • MVD和SRS均能有效缓解三叉神经痛,但MVD耐久性更优且药物减量更显著,代价是并发症率更高但风险可接受。
  • 低手术风险患者可能优先选择MVD,而SRS仍是有价值的无创选项。

研究设计与样本

  • 单中心回顾性队列分析,纳入290例1型三叉神经痛患者,2001年9月至2025年5月间接受MVD或SRS作为初始手术。
  • 收集人口学、影像、手术细节、用药及长期结局数据,统计显著性设为P < .05。

主要发现

  • MVD组患者显著年轻于SRS组(中位60 vs 74岁,P < .001)。
  • 控制年龄和性别后,MVD初始疼痛缓解更优(BNI:1.74 vs 1.96,P = .007,调整β -0.427 [95% CI, -0.738 to -0.117])。
  • MVD复发率更低(7.9% vs 22.6%,P < .001,调整OR 0.26 [95% CI, 0.12-0.56])。
  • SRS后面部麻木更频繁(34.5% vs 8.6%,P < .001,调整OR 0.18 [95% CI, 0.08-0.37])。
  • MVD药物减量百分比更大(-53.3% vs -17.5%,P < .001)。

关键数值与推荐

  • SRS无并发症发生,MVD并发症率为13.7%,多为轻微并保守处理。
  • 术前MRI显示血管冲突者MVD后复发率更低(7.9% vs 22.5%,P < .001)。
  • 术中无血管冲突而接受神经松解术者,药物减量优于SRS(53.3% vs 17.5%,P = .007),但疼痛评分和麻木率相似。

临床怎么用

  • 对低手术风险患者,MVD可能作为首选以获更持久疼痛缓解和药物减量。
  • SRS可作为无创选项,尤其适用于手术风险较高者,但需告知面部麻木风险。
  • 术前MRI可用于预测神经血管冲突,指导MVD患者选择;术中无冲突时可考虑神经松解术。

局限性

  • 回顾性单中心设计可能存在选择偏倚。
  • MVD组与SRS组年龄差异显著,虽经统计控制但残余混杂可能影响结果。
  • 原文未报告长期随访时长及失访情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Trigeminal neuralgia (TN) can be a severe, debilitating facial pain disorder often resistant to medical therapy. Microvascular decompression (MVD) and stereotactic radiosurgery (SRS) are widely used interventions, but the long-term comparative outcomes when each treatment is used as an index procedure remain unclear. We evaluated their efficacy and safety in a single-center cohort tracked over 2 decades. METHODS: We retrospectively reviewed 290 patients with type 1 TN who underwent MVD or SRS between September 2001 and May 2025. Data included demographics, imaging, procedural details, medication use, and long-term outcomes. Statistical significance was set at P < .05. RESULTS: Patients with MVD were significantly younger than SRS patients (median 60 vs 74 years, P < .001). When controlling for age and sex, MVD was superior in initial postprocedural pain relief (Barrow Neurological Institute: 1.74 vs 1.96, P = .007, adjusted β -0.427 [95% CI, -0.738 to -0.117]) and recurrence rate (7.9% vs 22.6%, P < .001, adjusted odds ratio 0.26 [95% CI, 0.12-0.56]). Postprocedural numbness was more frequent with SRS (34.5% vs 8.6%, P < .001, adjusted odds ratio 0.18 [95% CI, 0.08-0.37]). MVD achieved greater percent medication reduction (-53.3% vs -17.5%, P < .001). No complications occurred with SRS, whereas MVD had a 13.7% complication rate, mostly minor and managed conservatively. Recurrence after MVD was lower in patients with vascular conflict on preoperative MRI (7.9% vs 22.5%, P < .001). Patients without vascular conflict intraoperatively who underwent neurolysis had greater medication reduction than SRS (53.3% vs 17.5%, P = .007) but similar pain scores and numbness rates. CONCLUSION: Both MVD and SRS were effective in treating TN-associated pain, but MVD offers superior durability and medication reduction at the cost of higher complication rates but still an acceptable risk profile. MVD may be preferred for low surgical-risk patients, while SRS remains a valuable noninvasive option. MRI reliably predicts neurovascular conflict, and neurolysis may be considered when no vascular conflict is present.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Marincovich A, Mekala P, Lak A, et al. Outcomes of Microvascular Decompression Versus Stereotactic Radiosurgery in the Treatment of Trigeminal Neuralgia: A Decades-Long, Single-Center Retrospective Cohort Analysis. Neurosurgery. 2026. PMID: 42961028. doi:10.1227/neu.0000000000004270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。